Proteomics Data Analysis in R: A Practical Workflow for Differential Expression and Visualization

Proteomics data analysis in R requires a structured workflow that moves from raw quantitative output through quality control, normalization, statistical testing, and visualization. This article provides a practical framework for researchers and analysts working with label-free quantitative proteomics data, with emphasis on reproducible practices and defensible biological interpretation. The workflow assumes you have already generated peptide or protein intensity tables from a mass spectrometry platform and now need to perform downstream statistical analysis in R.

At a Glance

The table below summarizes the core stages of a proteomics data analysis workflow in R, the primary decisions at each stage, and the typical outputs you should expect.

Understanding Proteomics Data Structures in R

Proteomics data arrives in R through several common formats. The most frequent structure is a rectangular matrix where rows represent proteins or peptides and columns represent individual samples. Each cell contains an intensity value, often log-transformed, that reflects the abundance of that protein in that sample. A separate metadata table describes each sample, including experimental group, batch, and technical replicate information.

The FragPipe computational proteomics platform produces formatted output tables ready for downstream analysis, and tools such as FragPipe-Analyst provide an R Shiny interface for conducting statistical analysis and visualization. For users who prefer a script-based approach, the underlying R package supports the same functionalities. Similarly, the prolfqua package integrates quality control, normalization, protein aggregation, statistical modeling, hypothesis testing, and sample size estimation into a modular R application programming interface.

When you import data into R, you should preserve the distinction between the intensity matrix and the experimental design. The tidyproteomics package provides an open-source data object specifically designed for quantitative proteomics post-analysis and visualization, which can help maintain this separation. The package structures data in a way that supports consistent analysis workflows across different input formats.

Setting Up a Reproducible R Environment

Reproducibility begins before you load your first data file. Create a project directory with subfolders for raw data, processed data, scripts, figures, and results. Record the version of R and every package you use, because package updates can change function behavior and statistical output. The Bioconductor project offers training materials that emphasize reproducible analysis practices, and the European Bioinformatics Institute provides structured learning resources for computational biology workflows.

Your R script should begin with a header that documents the analysis date, the data files used, the software versions, and the purpose of the analysis. Use sessionInfo() at the end of your script to capture the complete environment. Save this output to a text file so you can reconstruct the exact analysis environment later.

Package management matters for long-term reproducibility. The Bioconductor workflow for processing, evaluating, and interpreting expression proteomics data demonstrates how a structured workflow can guide users through the entire analysis pipeline while maintaining reproducibility standards. Consider using the renv package to create a project-specific library that locks package versions.

Data Import and Initial Inspection

Load your protein intensity table using base R functions or the readr package. The choice of import function depends on your source file format. Most mass spectrometry software exports CSV or TSV files. After import, verify the dimensions of your data and check that protein identifiers are unique. Duplicate identifiers can arise when a protein is represented by multiple peptides or when the quantification software reports isoforms separately.

Inspect the structure of your data with str() and view the first few rows with head(). Check the range of intensity values and look for any obvious anomalies such as negative values, zero values, or missing entries. Missing values in proteomics data are common and arise from proteins that fall below the detection limit in some samples. The pattern of missingness carries biological information, so you should record how many missing values occur per protein and per sample before deciding how to handle them.

The scp package provides a standardized framework for mass-spectrometry-based single-cell proteomics data processing that relies on the QFeatures and SingleCellExperiment data structures. While designed for single-cell applications, the quality control principles apply to bulk proteomics as well. The workflow emphasizes quality control at the feature and cell level, aggregation of raw data into peptides and proteins, normalization, and batch correction.

Quality Control Before Normalization

Quality control should occur before any normalization or statistical testing. The goal is to identify problematic samples, assess overall data quality, and detect technical artifacts that could bias downstream analysis.

Sample-Level Quality Metrics

Calculate the total intensity for each sample and examine the distribution. Samples with unusually low total intensity may have experienced injection problems, poor digestion, or instrument failure. Samples with unusually high total intensity may indicate contamination or overloading. Plot total intensity as a bar chart ordered by sample to visualize these patterns.

Compute the number of proteins detected in each sample. A sample with substantially fewer detected proteins than the rest of the cohort may need to be excluded or re-run. The coefficient of variation for technical replicates should be lower than for biological replicates, and unusually high variation within technical replicates signals instrument instability.

Missing Value Assessment

Record the percentage of missing values for each protein and each sample. Proteins missing in more than half of the samples in every condition are often removed from downstream analysis because they provide limited statistical power. However, some proteins are genuinely present only in specific conditions, and their condition-specific missingness is biologically meaningful. The OmicScope tool performs data pre-processing that includes joining replicates, normalization, and data imputation, and it can handle both static and longitudinal experimental designs.

Batch Effect Detection

If your samples were processed in multiple batches, examine whether batch membership correlates with the first principal components of your data. The standardized workflow for mass-spectrometry-based single-cell proteomics includes batch correction as a core processing step. Visualize sample relationships using principal component analysis before normalization to see whether samples cluster by biological condition or by batch. Strong batch-driven clustering indicates that batch correction will be necessary before differential expression testing.

Normalization Strategies

Normalization adjusts for systematic technical variation across samples so that biological differences become detectable. The choice of normalization method depends on your data distribution, the expected proportion of changing proteins, and your experimental design.

Total Intensity Normalization

Total intensity normalization scales each sample so that the sum of all protein intensities is equal across samples. This method assumes that the total protein amount is similar across samples and that most proteins do not change between conditions. It works well when the proportion of differentially abundant proteins is small.

Median or Quantile Normalization

Median normalization centers each sample on its median intensity. Quantile normalization forces the distribution of intensities to be identical across all samples. These methods are more robust to outliers than total intensity normalization but assume that the overall distribution of protein abundances is similar across samples.

Variance Stabilizing Normalization

Variance stabilizing normalization transforms the data to reduce the relationship between mean intensity and variance. This approach is useful when your data show heteroscedasticity, meaning that high-abundance proteins have larger variance than low-abundance proteins. The prolfqua package supports multiple normalization approaches and provides benchmark functionality to compare data preprocessing methods using gold standard datasets.

Normalization Decision Criteria

Record which normalization method you choose and why. The decision should be based on diagnostic plots instead of habit. After normalization, re-examine the sample correlation matrix and principal component analysis to confirm that technical variation has been reduced. The POMAShiny workflow provides a structured and flexible approach to visualization, exploration, and statistical analysis of proteomics data, and it integrates several statistical methods within a reproducible framework.

Handling Missing Values

Missing values in proteomics data require explicit handling because most statistical tests cannot accommodate missing entries. You have three main options: remove proteins with excessive missingness, impute missing values, or use statistical models that accommodate missing data.

Filtering Proteins with Excessive Missingness

Set a threshold for the minimum number of valid observations per protein. A common approach is to require that a protein be quantified in at least 70 percent of samples in at least one experimental group. This filtering step reduces the number of statistical tests and improves power for the proteins that remain.

Imputation Methods

When you choose to impute, the method should reflect the reason for missingness. Missing values in proteomics often result from values falling below the detection limit, which is a form of missing not at random. In this case, imputation from a left-censored distribution, such as a low-abundance normal distribution, is more appropriate than simple mean imputation. The FragPipe-Analyst tool offers various missing value imputation options and supports downstream analysis workflows.

Recording Imputation Decisions

Document the imputation method, the parameters used, and the proportion of missing values that were imputed. Sensitivity analysis, where you repeat the differential expression analysis with different imputation approaches, can reveal whether your conclusions depend heavily on the imputation strategy. The OmicScope platform includes data imputation as part of its pre-processing pipeline and supports meta-analysis across independent datasets.

Differential Expression Analysis

Differential expression analysis identifies proteins whose abundance differs significantly between experimental conditions. The analysis requires a statistical model that accounts for the experimental design and a multiple testing correction to control false discoveries.

Statistical Modeling Approaches

The limma package is widely used for differential expression analysis of proteomics data. It fits a linear model for each protein and uses empirical Bayes moderation to borrow information across proteins, which stabilizes variance estimates for proteins with few observations. The FragPipe-Analyst workflow uses limma for differential expression analysis and supports gene ontology and pathway enrichment analysis.

For more complex experimental designs with multiple factors, the prolfqua package can model experiments with multiple explanatory variables and hypothesis testing. This package provides a modular interface that supports a variety of statistical procedures, making it easier to compare different modeling approaches.

Defining Contrasts

Before fitting models, define the contrasts you want to test. A contrast is a comparison between groups, such as treatment versus control or time point two versus time point one. Write your contrasts explicitly in the script so that the analysis records exactly which comparisons were made. For experiments with multiple factors, consider whether you need main effects, interaction terms, or both.

Multiple Testing Correction

When you test thousands of proteins simultaneously, the probability of false positives increases. Apply a false discovery rate correction, such as the Benjamini-Hochberg procedure, to adjust p-values. Report both the raw p-value and the adjusted p-value for each protein. The clusterProfiler package automates biological-term classification and enrichment analysis of gene clusters, and it supports the interpretation of differential expression results in a functional context.

Interpreting Differential Expression Results

A statistically significant result does not guarantee biological relevance. Consider the magnitude of the fold change alongside the adjusted p-value. A protein with a very small fold change may be statistically significant with a large sample size but biologically unimportant. Conversely, a protein with a large fold change may fail to reach significance due to high variance or small sample size.

The study of transcriptomic responses to developmental temperature in Spodoptera exigua illustrates how differential expression analysis can reveal population-associated variation in response to environmental conditions. In that study, differential expression analysis identified population-associated differences in pathways related to heat response, oxidative metabolism, cytoskeletal organization, cuticle-associated processes, lipid metabolism, and immune-related functions. This example shows how differential expression results can generate hypotheses about biological mechanisms.

Visualization for Exploration and Publication

Visualization serves two purposes in proteomics analysis: exploration during the analysis process and communication of results in publications. Different plot types serve different purposes, and you should match the visualization to the question you are asking.

Principal Component Analysis Plots

Principal component analysis reduces the dimensionality of your data and projects samples into a low-dimensional space. PCA plots are useful for examining overall sample relationships, detecting outliers, and assessing batch effects. Color points by experimental group and shape them by batch to see which factor drives the main variation in your data.

Volcano Plots

Volcano plots display the relationship between fold change and statistical significance. The x-axis shows log2 fold change and the y-axis shows negative log10 adjusted p-value. Points in the upper left and upper right corners represent proteins with large fold changes and high statistical significance. Add horizontal and vertical lines to indicate your significance thresholds.

Heatmaps

Heatmaps display the intensity values for a selected set of proteins across all samples. They are useful for visualizing expression patterns within clusters of proteins or samples. Before creating a heatmap, scale the rows so that each protein has a mean of zero and standard deviation of one. This scaling makes patterns visible across proteins with different absolute abundances.

Enrichment Analysis Visualizations

After identifying differentially expressed proteins, you may want to determine whether specific biological pathways or gene ontology terms are overrepresented. The clusterProfiler package supports enrichment analysis and provides visualization methods for enrichment results. The OmicScope platform performs over-representation analysis and gene set enrichment analysis using Enrichr with access to over 224 databases.

Publication-Ready Figure Standards

When preparing figures for publication, ensure that text is legible at final figure size, axis labels are descriptive, and color choices are accessible to color-blind readers. Save figures as vector formats such as PDF or SVG when possible. Record the exact code that generated each figure so that you can regenerate it if reviewers request changes.

Functional Enrichment and Pathway Analysis

Differential expression analysis produces a list of proteins, but biological interpretation requires placing those proteins in the context of pathways and functional categories. Enrichment analysis tests whether specific functional categories are overrepresented among your differentially expressed proteins compared to what would be expected by chance.

Over-Representation Analysis

Over-representation analysis compares the proportion of differentially expressed proteins in a given category to the proportion of all measured proteins in that category. This analysis requires a defined list of differentially expressed proteins and a background list of all proteins that were measured. The choice of background matters, and you should use the set of all quantified proteins instead of the entire genome.

Gene Set Enrichment Analysis

Gene set enrichment analysis uses the full ranking of proteins by test statistic instead of a binary differential expression call. This approach can detect coordinated changes in pathways where individual proteins do not reach significance. The OmicScope platform performs both over-representation analysis and gene set enrichment analysis, and its Nebula module facilitates meta-analysis from independent datasets.

Interpreting Enrichment Results

Enrichment results identify pathways that are statistically overrepresented, but statistical enrichment does not prove biological causation. Consider whether the enriched pathways make sense given your experimental system and whether the direction of change is consistent within the pathway. The integrated multi-omics analysis of glycosylceramide synthase-deficient human induced pluripotent stem cells demonstrated how quantitative proteomic analysis combined with pathway analysis can reveal enrichment of pathways associated with signal transduction and protein localization and transport.

Common Failure Patterns in Proteomics Analysis

Several recurring problems undermine proteomics analyses. Recognizing these patterns early can save time and prevent incorrect conclusions.

Failure to Document Analysis Decisions

The most common failure is inadequate documentation of choices made during analysis. Without records of normalization methods, imputation parameters, and statistical models, the analysis cannot be reproduced or defended. Maintain a lab notebook or electronic record that captures every decision and the rationale behind it.

Ignoring Missing Value Patterns

Treating all missing values as equivalent is a common error. Missing values that occur because a protein is absent in one condition carry different information than missing values caused by technical failure. Examine the pattern of missingness before deciding on a handling strategy.

Overlooking Batch Effects

Batch effects can masquerade as biological differences or obscure real differences. If samples from different conditions were processed in different batches, the analysis cannot distinguish batch effects from condition effects. Design experiments to randomize samples across batches whenever possible.

Applying Inappropriate Statistical Models

Using a statistical model that does not match the experimental design leads to incorrect p-values. Paired designs require paired tests, and experiments with multiple factors require models that include those factors. The prolfqua package supports both simple experimental designs with a single explanatory variable and complex experiments with multiple factors.

Misinterpreting Correlation as Causation

Proteomics data reveal associations, not causal relationships. A protein that correlates with a phenotype may be a cause, a consequence, or an unrelated correlate. The exploration of new biomarkers for rheumatoid arthritis used Mendelian randomization to assess whether protein expression and disease risk were influenced by shared genetic variants, an approach that strengthens causal inference beyond correlation alone.

Records and Measurements for Quality Assurance

Maintain structured records throughout the analysis to support quality assurance and regulatory compliance. The NIH Genomic Data Sharing Policy establishes expectations for data sharing and management that apply to many federally funded research projects. Even if your project is not federally funded, following these principles strengthens the credibility of your analysis.

Analysis Documentation Checklist

Record the version numbers of R and all packages used in the analysis. Save the raw data files in their original format and never modify them. Store processed data separately with clear file names that indicate the processing stage. Document the date each analysis step was performed and the person who performed it.

Data Management for Reproducibility

The FAIR Guiding Principles describe standards for making data findable, accessible, interoperable, and reusable. Apply these principles to your proteomics data by using standard file formats, descriptive metadata, and persistent identifiers. The NCBI Data Resources provide repositories for depositing proteomics data and making it available to the research community.

Version Control for Scripts

Use a version control system such as Git to track changes to your analysis scripts. Commit changes with descriptive messages that explain what was modified and why. This practice creates a complete history of your analysis and makes it possible to revert to earlier versions if needed.

Limitations and Interpretation Boundaries

Proteomics data analysis has inherent limitations that should inform your interpretation and reporting.

Coverage Limitations

Mass spectrometry does not detect every protein in a sample. Low-abundance proteins, hydrophobic proteins, and proteins with extreme molecular weights are underrepresented. Your analysis can only draw conclusions about the proteins that were detected and quantified.

Quantification Accuracy

Protein intensities are relative measurements, not absolute concentrations. Comparisons between proteins within a sample are not directly quantitative because different proteins ionize with different efficiencies. Comparisons of the same protein across samples are more reliable but still subject to technical variation.

Statistical Power Constraints

The number of biological replicates directly affects your ability to detect differential expression. With few replicates, only large fold changes will reach statistical significance. The prolfqua package includes sample size estimation functionality that can help you determine the number of replicates needed for future experiments.

The best practices for single-cell analysis across modalities emphasize that independent benchmarking studies are needed to navigate the landscape of computational tools and analysis steps. The same principle applies to bulk proteomics. Different tools may produce different results on the same dataset, and you should validate critical findings with an orthogonal method.

Professional Escalation Criteria

Some situations require consultation with a bioinformatics specialist, statistician, or collaborator with deeper expertise. Seek professional input when you encounter any of the following circumstances.

When to Consult a Statistician

Consult a statistician when your experimental design involves multiple factors with interactions, when you are unsure whether your data meet the assumptions of your chosen statistical test, or when you need to estimate sample sizes for a new experiment. A statistician can also help you interpret unexpected results and design sensitivity analyses.

When to Consult a Bioinformatics Specialist

Consult a bioinformatics specialist when you need to integrate proteomics data with other omics data types, when you are working with a non-standard data format, or when you need to implement custom analysis methods. The Bioconductor workflow for correlation profiling subcellular proteomics and the Bioconductor workflow for processing and analysing spatial proteomics data demonstrate specialized workflows that may require expert guidance.

When to Re-examine the Experimental Design

If your quality control analysis reveals strong batch effects that cannot be corrected, if samples cluster by processing date instead of biological condition, or if technical replicates show excessive variation, the experimental design or sample processing may need to be revised. These situations warrant discussion with the laboratory team before proceeding with statistical analysis.

When Results Conflict with Biological Knowledge

If your differential expression results contradict established biological knowledge in ways that cannot be explained, seek a second opinion. The spatial proteomics study in neurons at single-protein resolution demonstrates how advanced proteomics methods can reveal previously unknown biological complexity, but unexpected results should be validated before drawing strong conclusions.

Safety and Ethical Considerations

Proteomics data analysis involves handling data that may derive from human subjects or protected animal studies. The NIH Genomic Data Sharing Policy describes expectations for protecting research participant privacy while enabling data sharing. If your data include human samples, ensure that your analysis complies with applicable privacy regulations and institutional review board requirements.

The limited proteolysis-mass spectrometry protocol describes a technique for detecting protein structural alterations on a proteome-wide scale. This protocol includes experimental procedures that take approximately three days, with mass spectrometric measurement time and data processing depending on sample number. Statistical analysis typically requires about one day. When adapting published protocols, follow the safety guidelines provided in the original publications and your institutional biosafety requirements.

Frequently Asked Questions

What is the minimum number of biological replicates needed for proteomics differential expression analysis?

The number of replicates needed depends on the magnitude of the biological effect you want to detect, the technical variability of your platform, and the false discovery rate you are willing to accept. The prolfqua package includes sample size estimation functionality that can help you calculate the required number of replicates based on your specific parameters. In general, more replicates provide greater statistical power, and three biological replicates per condition is often considered a practical minimum for exploratory studies.

How should I choose between different normalization methods?

Choose a normalization method based on diagnostic plots of your data instead of habit. Examine whether total intensity differs substantially across samples, whether the proportion of changing proteins is expected to be large or small, and whether variance scales with mean intensity. After applying a candidate normalization method, check whether technical variation has been reduced and whether biological differences are more apparent. The prolfqua package provides benchmark functionality that can help you compare different preprocessing methods using gold standard datasets.

What is the difference between label-free quantification and tandem mass tag quantification for downstream analysis in R?

Label-free quantification compares protein intensities across separate mass spectrometry runs, while tandem mass tag quantification uses isobaric labels to multiplex samples within a single run. The data structures and normalization requirements differ between these approaches. The FragPipe-Analyst tool supports both label-free quantification and tandem mass tag workflows, and it also supports data-independent acquisition data.

How do I handle proteins with many missing values?

First, examine the pattern of missingness. If a protein is missing in most samples across all conditions, it likely falls below the detection limit and should be filtered out. If a protein is missing specifically in one condition, that pattern may be biologically meaningful. Set a filtering threshold based on the proportion of valid observations per group, and document your threshold in the analysis script.

What is the appropriate false discovery rate threshold for proteomics data?

A false discovery rate of 5 percent is commonly used, meaning that approximately 5 percent of the proteins called significant are expected to be false positives. You may choose a more stringent threshold, such as 1 percent, when the cost of false positives is high or when you are validating candidates for further study. Report the adjusted p-values for all proteins so that readers can apply their own thresholds.

Can I use transcriptomics analysis packages for proteomics data?

Many statistical methods developed for transcriptomics can be applied to proteomics data because both data types share similar structures. However, proteomics data have unique features, including different missing value patterns and a smaller dynamic range. The prolfqua package was designed specifically for proteomics differential expression analysis, and the POMAShiny workflow supports both metabolomics and proteomics data analysis.

How do I integrate proteomics results with other omics data types?

Integration of proteomics data with transcriptomics, genomics, or metabolomics data requires careful attention to identifier mapping and statistical methods that account for the different data structures. The integrated multi-omics analysis of glycosylceramide synthase-deficient stem cells combined quantitative proteomics with transcriptomic profiling and lipidomic analysis to reveal coordinated changes across molecular layers. The OmicScope platform supports meta-analysis from independent datasets for a systems biology approach.

What should I include in the methods section of my publication?

Your methods section should describe the data processing steps in enough detail that another researcher could reproduce the analysis. Include the software versions, normalization method, missing value handling strategy, statistical model, contrasts tested, and multiple testing correction method. The EMBL-EBI Training resources provide guidance on reporting standards for bioinformatics analyses.

Related Bioinformatics Guides

• Alternative Splicing Analysis from RNA-Seq Data
• RNA-Seq Differential Expression: DESeq2, edgeR, and limma-voom Frameworks
• Gene Ontology (GO) and Enrichment Analysis
• The KEGG Database and Pathway Analysis
• Predicting AMR from Genomic Data

References and Further Reading

• EMBL-EBI Training. European Bioinformatics Institute.
• NCBI Data Resources. National Center for Biotechnology Information.
• Genomic Data Sharing Policy. National Institutes of Health.
• The FAIR Guiding Principles. Scientific Data.
• Best practices for single-cell analysis across modalities.. Nature reviews. Genetics, 2023.
• clusterProfiler: an R package for comparing biological themes among gene clusters.. Omics : a journal of integrative biology, 2012.
• Spatial proteomics in neurons at single-protein resolution.. Cell, 2024.
• Proteome-wide structural changes measured with limited proteolysis-mass spectrometry: an advanced protocol for high-throughput applications.. Nature protocols, 2023.
• Standardized Workflow for Mass-Spectrometry-Based Single-Cell Proteomics Data Processing and Analysis Using the scp Package.. Methods in molecular biology (Clifton, N.J.), 2024.
• Analysis and Visualization of Quantitative Proteomics Data Using FragPipe-Analyst.. Journal of proteome research, 2024.
• POMAShiny: A user-friendly web-based workflow for metabolomics and proteomics data analysis.. PLoS computational biology, 2021.
• prolfqua: A Comprehensive R-Package for Proteomics Differential Expression Analysis.. Journal of proteome research, 2023.
• Transcriptomic responses to developmental temperature in two field-collected Spodoptera exigua populations from Korea.. 2026.
• Exploration of new biomarkers for rheumatoid arthritis based on plasma proteomics and transcriptome integrated with genome-wide Mendelian randomization.. 2026.
• Integrated Multi-omics Analysis Uncovers Molecular Dysregulation in Glycosylceramide Synthase-Deficient Human Induced Pluripotent Stem Cells.. 2026.
• OmicScope unravels systems-level insights from quantitative proteomics data. Nature Communications, 2024.
• A Bioconductor workflow for processing, evaluating, and interpreting expression proteomics data. F1000research, 2023.
• Tidyproteomics: an open-source R package and data object for quantitative proteomics post analysis and visualization. BMC Bioinformatics, 2023.
• An updated Bioconductor workflow for correlation profiling subcellular proteomics. F1000research, 2025.
• A Bioconductor workflow for processing and analysing spatial proteomics data. F1000research, 2018.

This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.